Daniel Freeland DO

Family Medicine•Lakeway, TX

Preventive Medicine, Sleep Medicine

Owner Bee Caves Family Practice

Join to View Full Profile

1008 Ranch Road 620 SSte 200Lakeway, TX 78734
Phone+1 512-263-9072
Fax+1 512-402-9057

Summary

Dr. Daniel Freeland is a family physician in Austin, TX and is affiliated with multiple hospitals in the area, including St. David's Medical Center and Baylor Scott & White - Lakeway. He received his medical degree from A.T. Still University Kirksville College of Osteopathic Medicine and has been in practice 27 years. He specializes in preventive medicine and sleep medicine and is experienced in diabetic neuropathy, chronic obstructive pulmonary disease, diabetes mellitus, general pediatrics, and chronic pain. Additionally he's expert in OMT (Osteopathic Manipulative Treatment).

Education & Training

A. T. Still University Kirksville College of Osteopathic MedicineClass of 1989
Truman State UniversityBS, Chemistry, 1981 - 1985

Certifications & Licensure

TX State License 1991 - 2026
OK State License 2024 - 2025
MI State License 1989 - 1990
AOA Board of Family Physicians Family Practice and Osteopathic Manipulative Medicine
AOBFPCertified Physician Investigator

Awards, Honors, & Recognition

President Texas Society of the ACOFP ACOFP/TXACOFP, 2015-2016

Clinical Trials

Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions Start of enrollment: 2003 Sep 01
Completed
Not Applicable
Bioequivalency Study of Zidovudine Under Fed Conditions Start of enrollment: 2003 Jun 01
Completed
Not Applicable
Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions Start of enrollment: 2003 Sep 01
Completed
Not Applicable
Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions Start of enrollment: 2003 May 01
Completed
Not Applicable
Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions Start of enrollment: 2004 Feb 01
Completed
Not Applicable
Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting Conditions Start of enrollment: 2004 Aug 01
Completed
Not Applicable
Bioequivalency Study of Zidovudine Under Fasting Conditions Start of enrollment: 2003 Jun 01
Completed
Not Applicable
Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions Start of enrollment: 2004 Aug 01
Completed
Not Applicable
Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg Start of enrollment: 2004 Dec 01
Completed
Phase 1
Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg Start of enrollment: 2004 Dec 01
Completed
Phase 1
Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions Start of enrollment: 2005 Jan 01
Completed
Not Applicable
Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions Start of enrollment: 2005 Jan 01
Completed
Not Applicable
Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions Start of enrollment: 2004 Aug 01
Completed
Phase 1
Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions Start of enrollment: 2004 Sep 01
Completed
Phase 1
Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on Applesauce Start of enrollment: 2004 Sep 01
Completed
Phase 1
A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce Start of enrollment: 2004 Oct 01
Completed
Phase 1
A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting Conditions Start of enrollment: 2004 Aug 01
Completed
Phase 1
A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions Start of enrollment: 2004 Sep 01
Completed
Phase 1
A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions Start of enrollment: 2004 Aug 01
Completed
Phase 1
A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions Start of enrollment: 2004 Oct 01
Completed
Phase 1
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions Start of enrollment: 2005 Feb 01
Completed
Not Applicable
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions Start of enrollment: 2005 Feb 01
Completed
Not Applicable
Join now to see all

Committees

Board member, Texas Society ACOFP 2010 - Present

Professional Memberships

ACOFP
Member
ACRP
CPI- Certified research professional
American Osteopathic Association - AOA
Member